/Investor DB

RC Capital — 2021 Investments

4 investments dated 2021 · listed companies and verified rows first · show all

Bardybardydx.cominDec 2021Acquired

BardyDx develops the Carnation Ambulatory Monitor (CAM), a lightweight cardiac patch monitor designed for extended-wear ambulatory ECG monitoring that emphasizes P-wave signal clarity.

Digital HealthHealthtechMedical DevicesSeattle, US

Gust H. Bardy(Executive Officer, Director, Promoter)Mark Querry(Executive Officer)Kevin Nelson, III(Executive Officer)Rik Vandevenne(Director)Alan Levy(Director)Mark Handfelt(Executive Officer, Promoter)

Co-investorsAPERTURE Venture PartnersAphelion CapitalAscension VenturesLumira VenturesRex Health VenturesSV Health Investors+2 more

Endodontic Practice Partnersendodonticpracticepartners.cominDec 2021

Endodontic Practice Partners (EPP) is a dental support organization that partners with endodontic practices, providing shared business resources, infrastructure, technology, and operational support to help them grow.

Healthtech

Dr. Terryl Propper(Executive Management Team / Founder)Sam Hutcheson(Executive Management Team / Founder)in

Q'Apel Medicalqapelmedical.cominFeb 2021 · $22M

Q'Apel Medical designs purpose-built devices for neurovascular and stroke care, developing tools focused on catheter access and navigation through complex vascular pathways.

HardwareHealthtechMedical DevicesFremont, US

R. King Nelson(Executive Officer, Director)inChristopher Martin(Director)J. Avi Roop(Director)Scot Huennekens(Director)

BoardCarter McNabb(Director)

Co-investorsResearch Corporation TechnologiesSoleus Capital

Veran Medicalveranmedical.comDec 2021Acquired

St.

HealthtechSt. Louis, US

Scott Wrightstone(Executive Officer)inMaureen Oehler(Executive Officer)Jason Pesterfield(Executive Officer, Director)inRyan Denney(Executive Officer)inMark Hunter(Executive Officer)inRobert Powers(Executive Officer)in

Co-investorsRex Health VenturesSolas BioVenturesAdvantage Capital PartnersVensana CapitalVersant Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.